Skip to main content

Adjuvant low-dose rituximab and plasma exchange for acquired TTP.

Publication ,  Journal Article
Zwicker, JI; Muia, J; Dolatshahi, L; Westfield, LA; Nieters, P; Rodrigues, A; Hamdan, A; Antun, AG; Metjian, A; Sadler, JE; ART Investigators
Published in: Blood
September 26, 2019

Duke Scholars

Published In

Blood

DOI

EISSN

1528-0020

Publication Date

September 26, 2019

Volume

134

Issue

13

Start / End Page

1106 / 1109

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Rituximab
  • Purpura, Thrombotic Thrombocytopenic
  • Plasma Exchange
  • Middle Aged
  • Male
  • Immunology
  • Immunologic Factors
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zwicker, J. I., Muia, J., Dolatshahi, L., Westfield, L. A., Nieters, P., Rodrigues, A., … ART Investigators. (2019). Adjuvant low-dose rituximab and plasma exchange for acquired TTP. Blood, 134(13), 1106–1109. https://doi.org/10.1182/blood.2019000795
Zwicker, Jeffrey I., Joshua Muia, Leili Dolatshahi, Lisa A. Westfield, Patricia Nieters, Anita Rodrigues, Ayad Hamdan, et al. “Adjuvant low-dose rituximab and plasma exchange for acquired TTP.Blood 134, no. 13 (September 26, 2019): 1106–9. https://doi.org/10.1182/blood.2019000795.
Zwicker JI, Muia J, Dolatshahi L, Westfield LA, Nieters P, Rodrigues A, et al. Adjuvant low-dose rituximab and plasma exchange for acquired TTP. Blood. 2019 Sep 26;134(13):1106–9.
Zwicker, Jeffrey I., et al. “Adjuvant low-dose rituximab and plasma exchange for acquired TTP.Blood, vol. 134, no. 13, Sept. 2019, pp. 1106–09. Pubmed, doi:10.1182/blood.2019000795.
Zwicker JI, Muia J, Dolatshahi L, Westfield LA, Nieters P, Rodrigues A, Hamdan A, Antun AG, Metjian A, Sadler JE, ART Investigators. Adjuvant low-dose rituximab and plasma exchange for acquired TTP. Blood. 2019 Sep 26;134(13):1106–1109.

Published In

Blood

DOI

EISSN

1528-0020

Publication Date

September 26, 2019

Volume

134

Issue

13

Start / End Page

1106 / 1109

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Rituximab
  • Purpura, Thrombotic Thrombocytopenic
  • Plasma Exchange
  • Middle Aged
  • Male
  • Immunology
  • Immunologic Factors
  • Humans
  • Female